INVO Bioscience (INVO) Institutional Ownership $0.88 +0.03 (+3.66%) As of 07/2/2025 Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for INVO Bioscience (NASDAQ:INVO)CurrentInstitutional OwnershipPercentage12.02%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$71.34KNumber ofInstitutional Sellers(last 12 months)0 Get INVO Insider Trade Alerts Want to know when executives and insiders are buying or selling INVO Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data INVO Institutional Buying and Selling by Quarter INVO Bioscience Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails10/23/2024CWC Advisors LLC.100,477$71K0.1%N/A2.638% 11/15/2023Sabby Management LLC231,023$183K0.1%N/A9.430% 11/14/2023AWM Investment Company Inc.32,000$25K0.0%-94.9%1.306% 11/4/2022Ieq Capital LLC50,000$53K0.0%N/A0.411% 8/12/2022AWM Investment Company Inc.623,860$411K0.1%-46.2%5.161% 5/12/2022Magnus Financial Group LLC18,000$48K0.0%+80.0%0.149% 4/12/2022Eidelman Virant Capital11,062$29K0.0%N/A0.091% 2/15/2022Connors Investor Services Inc.49,000$163K0.0%+27.3%0.418% 2/10/2022Magnus Financial Group LLC10,000$33K0.0%N/A0.085% 8/16/2021State Street Corp16,881$78K0.0%N/A0.161% 8/13/2021AWM Investment Company Inc.1,159,075$5.39M0.5%+22.0%11.077% 8/12/2021Essex Investment Management Co. LLC88,865$413K0.0%N/A0.849% 8/10/2021Connors Investor Services Inc.20,000$93K0.0%N/A0.191% 5/21/2021Citadel Advisors LLC22,721$98K0.0%N/A0.217% 5/19/2021Squarepoint Ops LLC32,661$141K0.0%N/A0.313% 5/18/2021Millennium Management LLC27,857$121K0.0%-50.3%0.267% 5/18/2021Citadel Advisors LLC22,721$98K0.0%N/A0.218% 5/12/2021Northern Trust Corp11,408$49K0.0%N/A0.109% 5/12/2021Geode Capital Management LLC81,346$352K0.0%N/A0.781% (Data available from 1/1/2016 forward) INVO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of INVO shares? During the previous two years, the following institutional investors and hedge funds held shares of INVO Bioscience shares: Sabby Management LLC ($183K), and CWC Advisors LLC. ($71K), AWM Investment Company Inc. ($25K).Learn more on INVO Bioscience's institutional investors. What percentage of INVO Bioscience's stock is owned by institutional investors? 12.02% of INVO Bioscience's stock is owned by institutional investors. Learn more on INVO's institutional investor holdings. Which institutional investors have been buying INVO Bioscience's stock? The following institutional investors have purchased INVO Bioscience's stock in the last 24 months: Sabby Management LLC ($231.02K), and CWC Advisors LLC. ($100.48K). How much institutional buying is happening at INVO Bioscience? Institutional investors have bought a total of 100,477 shares in the last 24 months. This purchase volume represents approximately $71.34K in transactions. Related Companies Biotricity Institutional Ownership NeuroMetrix Institutional Ownership T2 Biosystems Institutional Ownership Inari Medical Institutional Ownership Paragon 28 Institutional Ownership Bioventus Institutional Ownership Perspective Therapeutics Institutional Ownership Nevro Institutional Ownership InfuSystem Institutional Ownership InspireMD Institutional Ownership This page (NASDAQ:INVO) was last updated on 7/4/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredHave you heard of “E.I.”?Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing t...Behind the Markets | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share INVO Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
